أعرض في EDS

O424 Resistance development in virological failures with DRV/r or LPV/r: 96-week analysis of the Phase III TITAN trial in treatment-experienced patients

التفاصيل البيبلوغرافية
العنوان:	O424 Resistance development in virological failures with DRV/r or LPV/r: 96-week analysis of the Phase III TITAN trial in treatment-experienced patients
المؤلفون:	S De Meyer, Inge Dierynck, E Lathouwers, B Van Baelen, Gaston Picchio, E De Paepe, Frank Tomaka, MP de Béthune, Tony Vangeneugden
المصدر:	Journal of the International AIDS Society. 11:O46
بيانات النشر:	Wiley, 2008.
سنة النشر:	2008
مصطلحات موضوعية:	medicine.medical_specialty, business.industry, Public Health, Environmental and Occupational Health, Lopinavir, Gastroenterology, Virology, Treatment experienced, Atazanavir, Infectious Diseases, Nelfinavir, Indinavir, Internal medicine, medicine, Ritonavir, business, Saquinavir, Darunavir, medicine.drug
الوصف:	Purpose of the study In the randomised, controlled, Phase III TITAN trial, at week 96, significantly more patients on darunavir coadministered with low-dose ritonavir (DRV/r) than on lopinavir/r (LPV/r) achieved HIV-1 RNA
تدمد:	1758-2652
DOI:	10.1186/1758-2652-11-s1-o46
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c604d1a808d80120c1396a2cfcd5fa0 https://doi.org/10.1186/1758-2652-11-s1-o46
Rights:	OPEN
رقم الانضمام:	edsair.doi.dedup.....4c604d1a808d80120c1396a2cfcd5fa0
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	17582652
DOI:	10.1186/1758-2652-11-s1-o46